Comparison of somatostatin receptor scintigraphy with 111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay results in patients with neuroendocrine tumours

被引：0
|
作者：
Rodrigues, M. [1 ]
Heute, D. [1 ]
Gabriel, M. [1 ]
Putzer, D. [1 ]
Griesmacher, A. [1 ]
Virgolini, I. [1 ]
机构：
[1] Hietzing Hosp, Inst Nucl Med, Vienna, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [21] SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH INDIUM-111-DTPA-D-PHE-1-OCTREOTIDE IN MAN - METABOLISM, DOSIMETRY AND COMPARISON WITH IODINE-123-TYR-3-OCTREOTIDE
    KRENNING, EP
    BAKKER, WH
    KOOIJ, PPM
    BREEMAN, WAP
    OEI, HY
    DEJONG, M
    REUBI, JC
    VISSER, TJ
    BRUNS, C
    KWEKKEBOOM, DJ
    REIJS, AEM
    VANHAGEN, PM
    KOPER, JW
    LAMBERTS, SWJ
    JOURNAL OF NUCLEAR MEDICINE, 1992, 33 (05) : 652 - 658
  • [22] Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
    Putzer, Daniel
    Gabriel, Michael
    Henninger, Benjamin
    Kendler, Dorota
    Uprimny, Christian
    Dobrozemsky, Georg
    Decristoforo, Clemens
    Bale, Reto Josef
    Jaschke, Werner
    Virgolini, Irene Johanna
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (08) : 1214 - 1221
  • [23] Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
    Gotthardt, Martin
    Behe, Martin P.
    Grass, Julia
    Bauhofer, Artur
    Rinke, Anja
    Schipper, Meike L.
    Kalinowski, Marc
    Arnold, Rudolf
    Oyen, Wim J. G.
    Behr, Thomas M.
    ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1203 - 1211
  • [24] Biodistribution of a new chelated somatostatin analogue, [In-111-DOTA-D-Phe-1-Tyr-3]-octreotide; Comparison with [In-111-DTPA-D-Phe-1]-octreotide in humans.
    Krenning, EP
    Bakker, WH
    Kwekkeboom, DJ
    Kooi, PPM
    vanderPluijm, ME
    Behe, M
    Macke, H
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 382 - 382
  • [25] The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment
    Shi, W
    Buchanan, KD
    Johnston, CF
    Larkin, C
    Ong, YL
    Ferguson, R
    Laird, J
    CLINICAL ENDOCRINOLOGY, 1998, 48 (03) : 303 - 309
  • [26] Somatostatin Receptor PET in Neuroendocrine Tumors: 68Ga-DOTA-Tyr3-Octreotide vs. 68Ga-DOTA-Lanreotide
    Putzer, D.
    Kroiss, A.
    Waitz, D.
    Gabriel, M.
    Guggenberg, E.
    Uprimny, C.
    Decristoforo, C.
    Warwitz, B.
    Virgolini, I. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S273 - S273
  • [27] Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role
    Cimitan, M
    Buonadonna, A
    Cannizzaro, R
    Canzonieri, V
    Borsatti, E
    Ruffo, R
    De Apollonia, L
    ANNALS OF ONCOLOGY, 2003, 14 (07) : 1135 - 1141
  • [28] Somatostatin Receptor Scintigraphy with Indium-111-DTPA-D-Phe-l-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide
    Krenning, E. P.
    Bakker, W. H.
    Kooij, P. P. M.
    Breeman, W. A. P.
    Oei, H. Y.
    de Jong, M.
    Reubi, J. C.
    Visser, T. J.
    Bruns, C.
    Kwekkeboom, D. J.
    Reijs, A. E. M.
    van Hagen, P. M.
    Koper, J. W.
    Lamberts, S. W. J.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 : 123S - 129S
  • [29] Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients:: Biodistribution, kinetics, organ and tumor uptake
    Kwekkeboom, DJ
    Kooij, PP
    Bakker, WH
    Mäcke, HR
    Krenning, EP
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 762 - 767
  • [30] Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-d-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-d-Phe1-octreotide
    M. Bangard
    M. Béhé
    S. Guhlke
    R. Otte
    H. Bender
    H. R. Maecke
    H. J. Biersack
    European Journal of Nuclear Medicine, 2000, 27 : 628 - 637
12345